Avivagen Inc. announced the appointment of two new Directors, Mr. David Allan and Ms. Vanessa Grant, and the resignation of two past Directors, Dr. Janusz Daroszewski and Dr. Chandra Panchal. Mr. David Allan has considerable experience in life sciences, capital markets and corporate governance. Ms. Vanessa Grant is currently a business law partner in the Toronto office of the firm of Gowling Lafleur Henderson LLP, with a practice focusing on governance, corporate finance, mergers and acquisitions and private equity.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 CAD | -.--% | -.--% | -.--% |
2023 | Avivagen Inc. Announces New 500 Kg Order for OxC-beta | CI |
2023 | Avivagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 285K | |
+16.63% | 12.04B | |
+6.55% | 6.01B | |
+4.98% | 5.54B | |
+14.80% | 5.12B | |
-19.13% | 2.7B | |
+3.80% | 1.96B | |
-12.27% | 1.27B | |
-10.05% | 957M | |
-18.43% | 949M |
- Stock Market
- Equities
- VIV Stock
- News Avivagen Inc.
- Avivagen Inc. Announces Board Changes